(Q80126888)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1 reference

8

Cristina Gasparetto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1

David A Rizzieri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

6

Nelson J Chao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

9

Gwynn D Long

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

15

Jon P Gockerman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

14

Donna Niedzwiecki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

7

James J Vredenburgh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

12

Bonnie Toaso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Gregory J Sand

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Dean McGaughey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Joseph O Moore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Carlos DeCastro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Elizabeth Anderson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Tracy Foster

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Donna Adams

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

2408-2414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: a review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Docetaxel versus paclitaxel for antiangiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20245

7 January 2021

Identifiers

DOI

10.1002/CNCR.20245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160345%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference